Syntopix says receives positive results from Phase II cosmetic study
Syntopix Group PLC said it has received positive results from its Phase II cosmetic study in subjects with acneic skin.
Genentech, a member of the Roche Group announced that a pivotal Phase II study with vismodegib showed positive results in people with advanced basal cell carcinoma or BCC, for whom surgery is considered inappropriate.